 | Up a level |
Journal Article
Kahraman, Deniz, Holstein, Arne, Scheffler, Matthias 
ORCID: 0000-0002-9031-1368, Zander, Thomas, Nogova, Lucia, Lammertsma, Adriaan A., Boellaard, Ronald ORCID: 0000-0002-0313-5686, Neumaier, Bernd ORCID: 0000-0001-5425-3116, Dietlein, Markus, Wolf, Juegen and Kobe, Carsten
(2012).
Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non-Small Cell Lung Cancer Treated With Erlotinib.
Clin. Nucl. Med., 37 (11).
S. 1058 - 1065.
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 0363-9762
Thress, Kenneth S., Jacobs, Vivien, Angell, Helen K., Yang, James Chih-Hsin ORCID: 0000-0002-5586-5138, Sequist, Lecia V., Blackhall, Fiona ORCID: 0000-0001-8716-3395, Su, Wu-Chou ORCID: 0000-0003-2953-4105, Schuler, Martin, Wolf, Juegen, Gold, Kathryn A., Cantarini, Mireille, Barrett, J. Carl and Janne, Pasi A.
(2017).
Modulation of Biomarker Expression by Osimertinib: Results of the Paired Tumor Biopsy Cohorts of the AURA Phase I Trial.
J. Thorac. Oncol., 12 (10).
S. 1588 - 1595.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380